Interim Report Q2, 2021

April - June 2021

language version shall prevail.

Financial Summary

Second Quarter 2021

  • Reported net revenue amounted to 0.8 mSEK (0.3)
  • Other revenue amounted to 0.7 mSEK (0)
  • Earnings per share amounted to -0.4 SEK (-0.8)
  • Cash-flowamounted to -18.8 mSEK (-18,8)
  • Cash at the end of the period amounted to 50.4 mSEK (53.2)
  • Comprehensive income amounted to -21.4 mSEK (-26.2)

January - June 2021

  • Reported net revenue amounted to 2.7 mSEK (0.8)
  • Other revenue amounted to 1.0 mSEK (0)
  • Earnings per share amounted to -0.9 SEK (-1.6)
  • Cash-flowamounted to -37.4 mSEK (26.4)
  • Cash at the end of the period amounted to 50.4 mSEK (53.2)
  • Comprehensive income amounted to -41.3 mSEK (-49.8).

text. In the event of inconsistency or discrepancy between the Swedish version and this publication, the Swedish

CEO Statement

FRISQ's Capital Markets Day in May was a great opportunity to present where we are and where we are moving to. We could then, and can now, report that higher recurring revenues have had a positive effect on cash flow, along with a cost control that has shifted funds from administration to development and commercialization. That shift also includes increasing sales staff and expanding footprints in the UK.

We were then also able to present our innovative work with the platform; how we encourage and motivate patients to follow their care plans, how the plans become dynamic with the help of increased interaction and how these aspects also have attracted interest from the pharmaceutical industry.

The newly announced five year agreement with Capio Elderly and Mobile Care is a breakthrough and a commercial confirmation, based on the encouraging feedback that we have received, of the value and utility of the FRISQ platform.

We are also in the final stages of completing a reorganization of the management team: With Ulrika Jones as new CFO, Ulrika Kruse as new CCO, Lovisa Sunnerholm as new CMO from the beginning of August and also a new chief product manager soon to be in place that will bridge our strong innovation and development team with our growing sales team. With this, we have a line-up that is perfectly equipped for capitalizing on a post- pandemic future where health care decision makers will again focus on the prospects of improving outcomes through digitalization.

George Thaw, CEO, FRISQ

Events

During the quarter

  • Ulrika Jones nominated as CFO
  • On 20 May, a Capital Markets Day was arranged to present Frisq's current state of affairs with extra focus on the innovative developments. Also presenting were Sir David Haslam, Fellow at the Royal College of Physicians (on the British / international need for patient-centered care plan solutions) and Thorleif Nilsen, Capio Elderly and Mobile Care (on the collaboration with FRISQ).

After the period

  • FRISQ has signed a commercial agreement with Capio Elderly and Mobile Care. The agreement runs for 5 years and the order value amounts to SEK 15 million. The agreement enters into force on 1 July 2021 and replaces the previous pilot agreement, after FRISQ Care has been evaluated in competition with other systems

This publication is a translation of the original Swedish

Selected Key Indicators

Second Quarter

6 Months

Full Year

2021

2020

2021

2020

2020

SEK Thousands

Apr-Jun

Jan-Jun

Apr-Jun

Jan-Jun

Jan-Dec

Net revenue

773

260

2 723

827

1 367

Operating profit/loss

-21 421

-26 130

-41 312

-49 698

-208 060

Earnings per share, SEK

-0,4

-0,8

-0,9

-1,6

-7.3

Development costs, capitalized

3 200

1 628

4 536

6 204

8 587

Cash flow

-18 813

-18 764

-37 362

26 446

61 106

Cash and cash equivalents

50 449

53 151

50 449

53 151

87 811

Equity per share, SEK

1

6

1

6

3

Equity/assets ratio (%)

74

93

74

93

87

Share price at quarter end, SEK

3,8

9,6

3,8

9,6

3.8

Number of employees at the end of the period

27

37

27

37

29

Financial Calendar: | Q3 - October 28, 2021 | Q4 - January 27, 2022 | Financial reports: www.frisqholding.se

Contact: CEO George Thaw, investor@frisq.se, +46 (0)8 120 131 21; Certified Adviser: FNCA Sweden AB, info@fnca.se, +46 (0)8 528 00 399

Financial reporting - Consolidated

This publication is a translation of the original Swedish text. In the event of inconsistency or discrepancy between the Swedish version and this publication, the Swedish language version shall prevail.

Consolidated revenue and earnings. Q2

Consolidated net revenue for the quarter amounted to 0.8 mSEK (0.03). The revenue reported for the quarter includes a higher ratio of recurring license-based revenues than did the same quarter last year. However, the ongoing pandemic has slowed down sales and roll-outs.Other revenue amounted to 0.7 mSEK (0.0) and relate primarily to EU-financed commercially based innovation projects.

Consolidated operational costs before depreciation and write-downare primarily driven by staff costs, development and operational expenditures, and amounted to 18.0 mSEK (19.8), and is reported net including capitalized work on own account which amounted to 0.8 mSEK (0.9). The lower costs are explained by, and correspond to, the rise in balanced development costs.. Total depreciation and write-downof tangible and intangible asset amounted to 4.9 mSEK (6.6) Operating losses for the quarter amounted to -21.4mSEK (-26.1). Net financial costs amounted to -0.0mSEK (-0.0)and relate to interest costs for right-of-useassets. Tax loss carry forward amounted to mSEK 353.3 at the end of the reporting period. Comprehensive income for the quarter amounted to -

21.4 mSEK (-26.2).Investments, primarily development, amounted to 3.2 MSEK (1.6).

Consolidated profit

Second Quarter

6 Months

Full Year

and loss

2021

2020

2021

2020

2020

SEK thousands

Apr-Jun

Jan-Jun

Apr-Jun

Jan-Jun

Jan-Dec

Net revenue

773

260

2 723

827

1 367

Other operating income

695

5

1 020

5

442

Other external costs

-11 754

-9 830

-23 600

-21 435

-45 551

Staff costs

-7 079

-10 934

-13 343

-19 117

-35 022

Own work capitalized

813

919

1 626

2 742

4 064

Operational costs

-18 020

-19 845

-35 317

-37 810

-76 509

Depreciation/write-down

-4 869

-6 550

-9 738

-12 720

-133 360

Total operating costs

-22 889

-26 395

-45 055

-50 530

-209 869

EBIT

-21 421

-26 130

-41 312

-49 698

-208 060

Net financial income

5

-50

9

-126

-119

EBT

-21 416

-26 180

-41 303

-49 824

-208 179

Tax

0

0

0

0

-20 936

NET PROFIT

-21 416

-26 180

-41 303

-49 824

-229 115

Comprehensive income

Translation differences

0

0

0

0

0

COMPREHENSIVE

-21 416

-26 180

-41 303

-49 824

-229 115

INCOME

Earnings per share (SEK)

-0,4

-0,8

-0,9

-1,6

-7.3

Consolidated revenue and earnings, January - September 2021

Consolidated net revenue for the year to date amounted to 2.7 mSEK (0.8), while other revenue that relate primarily to EU-financed commercially based innovation projects amounted to 1.0 mSEK (0). Consolidated costs before depreciation and write-down amounted to

35.3 mSEK (37.8) and is reported net including capitalized work on own account which amounted to 1.6 mSEK (2.7). Total depreciation and write-down of tangible and intangible assets amounted to 9.7 mSEK (12.7). It is the Company's assessment that the ongoing Covid- 19 pandemic does not impact the valuation of assets on the financial statements.

Operating losses amounted to -41.3 mSEK (-49.7).Net financial costs amounted to -0.0 mSEK (-0.1) and relate primarily to interest costs on right-of-use assets. Total comprehensive income amounted to - 41.3mSEK (-49.8).Investments, primarily development costs, amounted to 4.5 mSEK (6.2) during the year.

Financial position

The balance sheet reflects continued investments in the proprietary product that amounted to 17.4 mSEK (33.0) at the end of the period. The lower net amount is not a reflection on future earnings expectations, but rather a reflection of the fact that the Company is fairly young and has adopted a conservative policy with low capitalization and high depreciation rates.

Goodwill amounted to mSEK 0 (104.5). Cash balance at the end of the period was MSEK 50.4 mSEK (53.2).

Consolidated Balance Sheet

2021

2020

2020

SEK thousands

Jun. 30

Jun. 30

Dec. 31

Capitalized development

17 374

32 978

20 899

Goodwill

0

104 490

0

Tangible assets

527

754

640

Right-of-use assets

10 603

5 668

3 128

Financial assets

0

0

0

Deferred tax assets

0

20 936

0

Total fixed assets

28 504

164 826

24 667

Accounts receivable

284

503

1 994

Other receivables

2 575

2 453

1 779

Cash in bank

50 449

53 151

87 811

Total current assets

53 308

56 107

91 584

TOTAL ASSETS

81 812

220 933

116 251

Share Capital

2 398

1 610

1 610

Share Capital under registration

0

0

788

Other contributed capital

492 487

417 182

492 391

Translation reserve

5

5

5

Accumulated profit/loss

-434 458

-213 863

-393 155

Total equity

60 432

204 934

101 639

Leasing liability; long-term

7 623

2 339

0

Lease liability; short-term

3 077

3 449

3 281

Accounts payable

3 432

2 657

5 159

Other liabilities

7 248

7 554

6 172

Total current liabilities

21 380

15 999

14 612

TOTAL EQUITY AND LIABILITIES

81 812

220 933

116 251

Change in Equity

Second Quarter

6 Months

Full Year

2021

2020

2021

2020

2020

SEK thousands

Apr-Jun

Apr-Jun

Jan-Jun

Jan-Jun

Jan-Dec

Opening balance

81 764

230 956

101 639

187 847

187 847

Net profit

-21 416

-26 180

-41 303

-49 824

-229 115

Warrant premium

84

112

215

112

379

New Issue1)

0

46

-119

66 799

142 528

Closing Balance

60 432

204 934

60 432

204 934

101 639

  1. New issues in quarter: no new issue was conducted during the quarter, but 119 tSEK relates to the new issue conducted in November, 2020 and registered in January, 2021.

Cash flow

QUARTER: Cash flow from operating activities amounted to -14.8 mSEK (-16.1) as a result of investments in product development in combination with, as yet limited revenues. Cash flow amounted to -18.8 mSEK (-18.8).Investment amounted to -3.2 mSEK (-1.1) related primarily to capitalized development. Financing amounted to -0.8 mSEK (-1.5).

YEAR TO DATE: Cash flow amounted to -37.4 mSEK (26.4) where ifinancing activities generated 1.7 mSEK (65.1). FRISQ does not have any debt financing and funds its operations through equity. See information of risks on dependence of external financing.

Cash flow

Second Quarter

6 Months

Full Year

2021

2020

2021

2020

2020

SEK thousands

Apr-Jun

Apr-Jun

Jan-Jun

Jan-Jun

Jan-Dec

Earnings before taxes

-21 416

-26 180

-41 303

-49 824

-208 179

Depreciation/write-down

4 869

6 550

9 738

12 720

133 360

Other non-cash items

84

170

215

170

551

Change in working capital

1 665

3 315

263

3 950

4 312

Cash flow from

Operating activities

-14 798

-16 145

-31 087

-32 984

-69 956

Investment activities

-3 200

-1 128

-4 536

-5 704

-8 209

Financing activities

-815

-1 491

-1 739

65 134

139 271

Cash flow for the period

-18 813

-18 764

-37 362

26 446

61 106

Cash at beginning of period

69 262

71 915

87 811

26 705

26 705

Cash at close of period

50 449

53 151

50 449

53 151

87 811

Interim Report Q2, 2021

2

This publication is a translation of the original Swedish text. In the event of inconsistency or discrepancy between the Swedish version and this publication, the Swedish language version shall prevail.

Financial reporting - Parent Company

Parent Company Profit and Loss

2021

2020

SEK thousand

Jan-Jun

Jan-Jun

Net revenue

2 927

900

Other operating income

2

9

Other external costs

-5 614

-5 031

Staff costs

-917

-672

Total operating expenses

-6 531

-5 703

EBIT

-3 602

-4 794

Net financial income

-17 938

8

EBT

-21 540

-4 786

Tax

0

0

NET PROFIT

-21 540

-4 786

FRISQ Holding AB's primary focus is Group administration. Net revenue amounted to 2.9 mSEK (0.9) year to date and reflect invoicing to subsidiaries for administrative services. Operating losses amounted to -3.6 MSEK (-4.8) year to date. Costs in the Parent Company are primarily driven by the company's listing on Nasdaq First North. Net financial income amounted to MSEK -17.9 mSEK (0) and relates to impairment of shares in the subsidiary FRISQ AB.

Parent Company Balance Sheet

2021

2020

SEK thousand

Jun. 30

Dec. 31

Financial assets

29 063

29 063

Total fixed assets

47 063

29 063

Other receivables

852

774

Cash in bank

47 648

68 924

Total current assets

48 500

69 698

TOTAL ASSETS

77 563

98 761

Share capital

2 398

1 610

Share capital under registration

0

788

Share premium reserve

491 641

491 761

Accumulated profit/loss

-418 059

-396 735

Total equity

75 980

97 424

Accounts payable

908

1 112

Other liabilities

675

225

Total current liabilities

1 583

1 337

TOTAL EQUITY AND LIABILITIES

77 563

98 761

Number of Shares

Second Quarter

6 Months

Full Year

2021

2020

2021

2020

2020

Number of Shares

Apr-Jun

Apr-Jun

Jan-Jun

Jan-Jun

Jan-Dec

Opening

47 954 773

32 204 773

32 204 773

23 918 202

23 918 202

Closing

47 954 773

32 204 773

47 954 773

32 204 773

32 204 773

Average

47 954 773

32 204 773

47 084 607

30 611 202

31 412 341

The new issue conducted in November 2020, was registered in January 2021, at which time the number of shares increased by 15,750,000 to 47,954,773.

Employees

The average number of employees during the quarter was 26 (37). At the close of the quarter FRISQ had 27 (37) employees. There have been no material transactions with related parties other than one Board Members who have invoiced a total of TSEK 60.

Warrant programs

The warrant programs issued in FRISQ Holding AB aim to align shareholders and employee incentives. The warrants have been transferred at market price based on independent valuations and are subject to customary recalculations in connection with share issues, etc. For additional information see AGM announcements from relevant years.

Program 2017, a direct issue where warrants were issued to secure FRISQ's commitment, given fulfillment of certain conditions, to pay an additional consideration for the acquisition of new care path concepts, and associated prototype code. It allows a maximum 1,100,000 warrants each entitling to the subscription of one share, by no later than 31 May 2022, at a price of 0.05 SEK corresponding to the share's quota value.

Program 2020/2026, for the Director Lars Björk for his involvement in the establishment of FRISQ in the US. The program includes 320,000 warrants, of which 300,000 warrants are awarded to Lars Björk without consideration, and 20,000 are allocated to cover related. The warrants are earned over three years. Each warrant carries the right to subscribe to one new share, by 15 April 2026, at a price of 11.44 SEK. If fully subscribed, the Company's share capital will increase by SEK 16 000.

Program 2020/2024, with a maximum of 2,000,000 warrants (maximum of approximately 4% of total shares), aimed at key employees and individuals in the Group. The subscription period is 1 January - 31 March 2024. Each warrant entitles the holder to subscribe to one share at a price corresponding to 200 % of the average volume weighted price 1-12 March 2021; but no lower than 9 SEK/share. If fully subscribed, the Company's share capital will increase by SEK 100 000.

Full subscription of the above programs would increase the total number of shares by 7,1%.

Accounting principles and other information

Shares FRISQ Holding AB's shares are traded on Nasdaq First North under the stock symbol FRISQ since October 12, 2016. The number of shares as per end of the period were 47 954 773.

The Group Structure encompasses the parent company FRISQ Holding AB, org. no. 556959-2867 and the wholly owned subsidiaries FRISQ AB, org. no. 556783-5664; FRISQ USA Holding Inc., with its own wholly owned US based subsidiary FRISQ LLC; and FRISQ UK Ltd. The US and UK subsidiaries are in the process of being established. The Group's operating activities are conducted in FRISQ AB.

The accounting principles governing this report adhere to the Swedish Annual Accounts Act, and IFRS as adopted by the EU and RFR 1. The Parent Company applies the Annual Accounting Act and RFR 2. This report has been prepared in accordance with IAS 34. The accounting policies applied herein are consistent with the latest published Annual Report. New and amended standards adopted from the current year are not deemed to have any material impact on the Group's financial position.

This report has not been reviewed by the company's auditor.

Risks and uncertainties exist given that FRISQ is a relatively young company with limited revenue generation. It is therefore not yet possible to make sales or profit predictions until a stable earning level is achieved. As long as product development continues, the company is in need of additional external capital injections. FRISQ is dependent upon being able to enter into licensing and partnership agreements and upon several permits, remuneration systems and associated laws, regulations, decisions by government authorities and praxes (which can change). FRISQ is also dependent on intellectual property rights which are difficult to protect via registration. In addition, FRISQ is dependent on the access to care staff - which is difficult to predict under the current pandemic. The Board's view of risks and uncertainties has not changed. For further information, see Risks and Uncertainties in the last published Annual Report.

Statement of assurance This report has been adopted by the Board of FRISQ Holding AB on 15 July 2021. The Board and the Managing Director, certify that this interim report provides a fair assessment of the Parent Company, Group's activities, financial position, profits and describes material risks and uncertainties.

.

Interim Report Q2, 2021

3

Attachments

  • Original document
  • Permalink

Disclaimer

Frisq Holding AB published this content on 15 July 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 15 July 2021 06:04:27 UTC.